Autolus Therapeutics (AUTL) Non Operating Income: 2017-2025
Historic Non Operating Income for Autolus Therapeutics (AUTL) over the last 4 years, with Sep 2025 value amounting to -$7.0 million.
- Autolus Therapeutics' Non Operating Income rose 50.94% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.8 million, marking a year-over-year increase of 204.68%. This contributed to the annual value of $22.3 million for FY2024, which is 177.67% up from last year.
- As of Q3 2025, Autolus Therapeutics' Non Operating Income stood at -$7.0 million, which was down 150.85% from $13.7 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Non Operating Income high stood at $49.7 million for Q4 2024, and its period low was -$23.9 million during Q4 2023.
- In the last 3 years, Autolus Therapeutics' Non Operating Income had a median value of -$2.7 million in 2025 and averaged -$83,182.
- Its Non Operating Income has fluctuated over the past 5 years, first slumped by 1,882.74% in 2024, then skyrocketed by 1,834.60% in 2025.
- Quarterly analysis of 4 years shows Autolus Therapeutics' Non Operating Income stood at $4.2 million in 2022, then slumped by 666.79% to -$23.9 million in 2023, then surged by 307.82% to $49.7 million in 2024, then spiked by 50.94% to -$7.0 million in 2025.
- Its last three reported values are -$7.0 million in Q3 2025, $13.7 million for Q2 2025, and -$2.7 million during Q1 2025.